Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 4

Pulmonary and systemic hepatocyte and keratinocyte growth factors in patients with chronic obstructive pulmonary disease

Authors Sauleda J, Noguera A, Blanquer D, Pons J, López M, Villena C, Agustí AGN

Published 5 December 2008 Volume 2008:3(4) Pages 719—725

DOI https://doi.org/10.2147/COPD.S3078

Review by Single anonymous peer review

Peer reviewer comments 4



Jaume Sauleda1, Aina Noguera2, David Blanquer3, Jaume Pons4, Meritxell López1, et al

1Servei de Pneumologia, Hospital Universitari Son Dureta, Fundació Caubet-Cimera Illes Balears, Illes Balears, CIBER Enfermedades respiratorias, Illes Balears, Spain; 2Inmunologia, 4Anàlisis Clínique, Hospital Universitari Son Dureta. Palma Mallorca, Spain; 3Fundació Hospital Manacor, Manacor, Illes Balears Spain

Background: The potential role of growth factors in chronic obstructive pulmonary disease (COPD) has begun to be addressed only recently and is still poorly understood. For this study, we investigated potential abnormalities of hepatocyte growth factor (HGF) and keratinocyte growth factor (KGF) in patients with COPD.

Methods: To this end, we compared the levels of HGF and KGF, measured by enzyme-linked immunosorbent assay (ELISA), in bronchoalveolar lavage (BAL) fluid and in serum in 18 patients with COPD (62 ± 9 yrs, forced expiratory volume in one second [FEV1] 57 ± 12% ref, X ± standard deviation of mean), 18 smokers with normal lung function (58 ± 8 yrs, FEV1 90 ± 6% ref) and 8 never smokers (67 ± 9 yrs, 94 ± 14% ref).

Results: We found that in BAL, HGF levels were higher in patients with COPD than in the other two groups whereas, in serum, HGF concentration was highest in smokers with normal lung function (p < 0.01). KGF levels were not significantly different between groups, neither in blood nor in BAL (most values were below the detection limit).

Conclusions: These results highlight a different response of HGF in BAL and serum in smokers with and without COPD that may be relevant for tissue repair in COPD.

Keywords: COPD, growth factors, tissue repair

Creative Commons License © 2008 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.